DEA boosts cannabis & psilocybin quotas ahead of FDA approval (Newsletter: September 2, 2021)


NY marijuana regulatory officials confirmed; Senators get comments on cannabis bill; Seattle task force: Decrim all drugs; MA’s $2B in marijuana sales Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. (function() { window.mc4wp = window.mc4wp || { listeners: [], forms: { on: function(evt, cb) { window.mc4wp.listeners.push( { event : evt, callback: cb } ); } } } })(); Email address: Leave this field empty if you’re human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: / TOP THINGS TO KNOW The Drug Enforcement Administration proposed a massive increase in the amount of marijuana and psilocybin that can be legally produced for research, which it says are “necessary steps toward potential Food and Drug Administration (FDA) approval of new drug products.” Several major cannabis advocacy and industry organizations submitted comments on Senate Majority Leader Chuck Schumer’s (D-NY) draft federal marijuana legalization bill. Marijuana Moment compiled a look at concerns about taxes, equity, interstate commerce, licensing and more that were raised by groups. New York Gov. Kathy Hochul (D) appointed—and the Senate confirmed—two key officials who will be responsible for getting the state’s legal marijuana market off the ground. Seattle, Washington’s Overdose Emergency Innovative Recovery task force is recommending that the city decriminalize all drugs—and says psychedelics in particular could be a promising treatment to address substance abuse disorders and…

Excerpt only …
Source : DEA boosts cannabis & psilocybin quotas ahead of FDA approval (Newsletter: September 2, 2021)

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.